The influence of LC staging in the PARP protein expression levels found in tumor specimens of all of the patients taken as a whole, revealed that patients in stage I exhibited the greatest amount of PARP-1 expression compared to the other LC stages (Figure 5A). The gene discussed is PARP1; the disease is laryngotracheoesophageal cleft.